Careful study of genes responsible for rare Mendelian forms of human neurological disorders is an powerful approach for gaining insight into the causes, treatment, and potential cure for common, related diseases. The KCNQ genes were recently discovered as the result of the search for mutant genes causing Benign Neonatal Familial Convulsions, an autosomal dominant epileptic syndrome associated with seizures in infancy and throughout life. KCNQ genes encode voltage-dependent potassium channels called M-channels. M-channels regulate neuronal excitability by serving as effectors for neurotransmitter receptors and intracellular signaling pathways. Determining how these receptors and pathways modulate M-channels will enhance our ability to exploit M-channels as therapeutic targets in conditions involving excessive excitability or alterations and imbalances in modulatory neurotransmission, such as epilepsy, pain syndromes, and Alzheimer's disease. Because M-channels are large, oligomeric proteins and appear to be regulated by several distinct intracellular pathways, a novel, comprehensive approach to understanding their regulatory mechanisms is warranted. This proposed research approach exploits new instrumentation and analytical methods in mass spectrometry to identify sites of in vivo phosphorylation on KCNQ subunits. A combination of electrophysiological and cellular and molecular biological methods will then be used to determine the consequences of phosphorylation at the identified sites. The proposal involves a new collaboration between individuals with expertise in the clinical and genetic aspects of epilepsy, ion channel physiology, and proteomics. In addition to addressing specific questions concerning M-channel regulation, the proposed research will contribute to the development of mass spectrometric methods and the adaptation of these methods to the study of signaling proteins that are large, complex, and expressed either transiently, locally, or at low abundance in the brain. Because such signaling proteins play essential roles in brain development and in the maintenance of normal brain structure and activity, the proposed research may result in enhanced methodologies of broad usefulness for research into anomalous neurodevelopment, degeneration, and injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS042100-04
Application #
6658082
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Tagle, Danilo A
Project Start
2001-09-15
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2005-08-31
Support Year
4
Fiscal Year
2003
Total Cost
$198,125
Indirect Cost
Name
University of Pennsylvania
Department
Neurology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Kang, Seungwoo; Xu, Mingxuan; Cooper, Edward C et al. (2014) Channel-anchored protein kinase CK2 and protein phosphatase 1 reciprocally regulate KCNQ2-containing M-channels via phosphorylation of calmodulin. J Biol Chem 289:11536-44
Kuramoto, Nobuyuki; Wilkins, Megan E; Fairfax, Benjamin P et al. (2007) Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase. Neuron 53:233-47
Surti, Toral S; Huang, Lan; Jan, Yuh Nung et al. (2005) Identification by mass spectrometry and functional characterization of two phosphorylation sites of KCNQ2/KCNQ3 channels. Proc Natl Acad Sci U S A 102:17828-33
Cooper, Edward C; Jan, Lily Y (2003) M-channels: neurological diseases, neuromodulation, and drug development. Arch Neurol 60:496-500
Cooper, E C; Harrington, E; Jan, Y N et al. (2001) M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J Neurosci 21:9529-40